The 14th MedTech Investing Europe Conference Returns

The 14th MedTech Investing Europe Conference returns with an excellent speaker line up and agenda, which has been specifically designed with industry leaders to cover the most up to date issues in medical technologies.

Network with the top international medtech investment international community

Last year MTI London was attended by almost 200 delegates from 16 countries representing leading investors, major healthcare corporations and medical technology companies at different stages of investment.

The programme has been improved with over 30 companies presenting their latest technologies such as: Abionic SA, Adoptics AG, Araclon Biotech, Aespira Ltd, Axanton, BIOLAND d.o.o., CardioGal Ltd, Inc., CeQur SA, Diagnoplex SA, EPha.ch AG, Erib AG, eZono AG, Fluxome A/S, Geneva Biotech, ICNet International, Innovacell Biotechnologie AG, Laserix Sarl, LunGuard Medical, Medicwave, Medlumics S.L., MindMaze, Odus Technologies SA, Ortoma, Pluromed inc, PowerSens, Protaffin, RapiDx Ltd, Relaxbirth Ltd, Sensimed AG, StereoTools SA, ValveXchange, Inc, Virogates, Windgan Holding SA and more…

To view the updated list, please visit: MTI Europe 2012

Key speakers will include:

Oern Stuge, Founder, ORSCO Lifesciences AG, Germany

Herb Riband, Vice President External Affairs International, Medtronic International, Switzerland

Bulend Corbacioglu, Vice President, Business Development & Licensing, Covidien, USA

Conor Hanley, CEO, BiancaMed, Ireland

Corinne Lebourgeois, Managing Director, MedC Partners, Switzerland

Hélène Chevrou-Séverac, Global Head, Health Economics & Market Access, Nestlé Health Sciences, Switzerland

Antoine Papiernik, Managing Partner, Sofinnova Partners SA, France

Laura Piccinini, President, Stryker Europe, Italy

And more…

**Don’t delay – book now and save 40% on your registration with Medlatest**

Simply book your place by downloading the special booking form here.

With all the key players under one roof, don’t miss the opportunity to explore the very latest innovation and investment opportunities, engage in private discussions with prospective partners and gain first hand insight into who is investing and on what.

For more information on this event, please call Kekeli Sodji on +44 (0)207 214 0519 or email kekelisodji@campden.com